02.10.2015 Views

studies

2015SupplementFULLTEXT

2015SupplementFULLTEXT

SHOW MORE
SHOW LESS
  • No tags were found...

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

1226A AASLD ABSTRACTS HEPATOLOGY, October, 2015<br />

2087<br />

Polymorphisms in the interleukin (IL)-1 gene cluster are<br />

associated with multiple markers of systemic inflammation<br />

in patients with Acute-on-Chronic Liver Failure<br />

(ACLF)<br />

Jose Alcaraz-Quiles 1 , Esther Titos 4 , Cristina Lopez-Vicario 1 ,<br />

Bibiana Rius 1 , Aritz Lopategi 1 , Mireia Casulleras 1 , Veronica<br />

Garcia-Alonso 1 , Andrea De Gottardi 5 , Mauro Bernardi 3 , Ivo Graziadei<br />

6 , Henning Gronbaek 7 , Pere Gines 8,4 , Vicente Arroyo 8,2 ,<br />

Joan Clària 1,2 ; 1 Department of Biochemistry and Molecular Genetics,<br />

Hospital Clínic-University of Barcelona, Bareclona, Spain;<br />

2 University of Barcelona, Barcelona, Spain; 3 EASL-CLIF Consortium,<br />

Barcelona, Spain; 4 CIBERehd, Barcelona, Spain; 5 University<br />

of Berne, Berne, Switzerland; 6 Innsbruck Medical University,<br />

Innsbruck, Austria; 7 Aarhus University Hospital, Aarhus, Denmark;<br />

8 Liver Unit, Hospital Clinic, Barcelona, Spain<br />

Background and aim: Acute-on-Chronic liver failure (ACLF) is<br />

an increasingly recognized entity encompassing multiorgan<br />

failure in patients with cirrhosis. Recent findings suggest that<br />

immune dysregulation predisposes decompensated cirrhotic<br />

patients to a cycle of adverse events culminating in uncontrolled<br />

systemic inflammation and ACLF progression. Although<br />

the exact mechanisms leading to inflammation-driven ACLF<br />

remain to be elucidated, systemic inflammation is influenced by<br />

multiple genes regulating the innate immune response. In this<br />

study, we screened a set of six inflammation-related genes in<br />

a population-based study of patients with decompensated liver<br />

cirrhosis. Patients and Methods: Two hundred seventy-nine cirrhotic<br />

patients (178 with ACLF and 101 without ACLF) from the<br />

CANONIC study of the CLIF consortium were genotyped for<br />

SNP polymorphisms in genes coding for IL-1beta (rs1143623,<br />

G/C), IL-1 receptor antagonist (IL-1Ra) (rs4251961, T/C),<br />

SOCS3 (rs4969170, G/A), NOD2 (rs3135500, G/A),<br />

CMKLR1 (rs1878022, T/C) and IL-10 (rs1800871, G/A) by<br />

allellic discrimination TaqMan assays. Serum cytokine levels<br />

were measured by fluorescent bead-based (Luminex) immunoassays.<br />

Results: Among the six SNPs analyzed, we identified<br />

two polymorphisms belonging to the IL-1 gene cluster (IL-1beta,<br />

rs1143623 and IL-1Ra, rs425196) in strong association with<br />

ACLF. Homozygous C carriers in the rs1143623 SNP showed<br />

lower serum levels of IL-1β in parallel with reduced markers<br />

of systemic inflammation (i.e. IL-1alpha, IL-6 and TNF-alpha).<br />

Also, heterozygous TC carriers of the rs425196 SNP had<br />

lower serum levels of IL-1beta, IL-1alpha, IL-6, TNF-alpha and<br />

IL-8. Under different inheritance models, both genotypes were<br />

protective factors for presence of ACLF (rs1143623; OR: 0.34,<br />

p

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!